Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Neuroscience Market, by Component
1.4.2 Europe Neuroscience Market, by Technology
1.4.3 Europe Neuroscience Market, by End User
1.4.4 Europe Neuroscience Market, by Country
1.5 Methodology for the research
Chapter 2. Market At a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
Chapter 4. Competition Analysis - Global
4.1 KBV Cardinal Matrix
4.2 Recent Industry Wide Strategic Developments
4.2.1 Partnerships, Collaborations and Agreements
4.2.2 Product Launches and Product Expansions
4.2.3 Acquisition and Mergers
4.2.4 Trials and Approvals
4.3 Top Winning Strategies
4.3.1 Key Leading Strategies: Percentage Distribution (2019-2023)
4.3.2 Key Strategic Move: (Partnerships, Collaborations & Agreements: 2020, Oct– 2023, Jul) Leading Players
4.4 Porter Five Forces Analysis
Chapter 5. Europe Neuroscience Market by Component
5.1 Europe Instruments Market by Country
5.2 Europe Consumables Market by Country
5.3 Europe Software & Services Market by Country
Chapter 6. Europe Neuroscience Market by Technology
6.1 Europe Brain Imaging Market by Country
6.2 Europe Stereotaxic Surgeries Market by Country
6.3 Europe Neuro-Microscopy Market by Country
6.4 Europe Neuro-Proteomic Analysis Market by Country
6.5 Europe Neuro-Cellular Manipulation Market by Country
6.6 Europe Others Market by Country
Chapter 7. Europe Neuroscience Market by End User
7.1 Europe Diagnostic Laboratories Market by Country
7.2 Europe Hospitals Market by Country
7.3 Europe Research & Academic Institute Market by Country
Chapter 8. Europe Neuroscience Market by Country
8.1 Germany Neuroscience Market
8.1.1 Germany Neuroscience Market by Component
8.1.2 Germany Neuroscience Market by Technology
8.1.3 Germany Neuroscience Market by End User
8.2 UK Neuroscience Market
8.2.1 UK Neuroscience Market by Component
8.2.2 UK Neuroscience Market by Technology
8.2.3 UK Neuroscience Market by End User
8.3 France Neuroscience Market
8.3.1 France Neuroscience Market by Component
8.3.2 France Neuroscience Market by Technology
8.3.3 France Neuroscience Market by End User
8.4 Russia Neuroscience Market
8.4.1 Russia Neuroscience Market by Component
8.4.2 Russia Neuroscience Market by Technology
8.4.3 Russia Neuroscience Market by End User
8.5 Spain Neuroscience Market
8.5.1 Spain Neuroscience Market by Component
8.5.2 Spain Neuroscience Market by Technology
8.5.3 Spain Neuroscience Market by End User
8.6 Italy Neuroscience Market
8.6.1 Italy Neuroscience Market by Component
8.6.2 Italy Neuroscience Market by Technology
8.6.3 Italy Neuroscience Market by End User
8.7 Rest of Europe Neuroscience Market
8.7.1 Rest of Europe Neuroscience Market by Component
8.7.2 Rest of Europe Neuroscience Market by Technology
8.7.3 Rest of Europe Neuroscience Market by End User
Chapter 9. Company Profiles
9.1 Carl Zeiss AG
9.1.1 Company Overview
9.1.2 Financial Analysis
9.1.3 Segmental and Regional Analysis
9.1.4 Research & Development Expenses
9.1.5 Recent strategies and developments:
9.1.5.1 Partnerships, Collaborations, and Agreements:
9.1.5.2 Product Launches and Product Expansions:
9.1.6 SWOT Analysis
9.2 Danaher Corporation
9.2.1 Company Overview
9.2.2 Financial Analysis
9.2.3 Segmental and Regional Analysis
9.2.4 Research & Development Expense
9.2.5 Recent strategies and developments:
9.2.5.1 Acquisition and Mergers:
9.2.6 SWOT Analysis
9.3 Abbott Laboratories
9.3.1 Company Overview
9.3.2 Financial Analysis
9.3.3 Segmental and Regional Analysis
9.3.4 Research & Development Expense
9.3.5 Recent strategies and developments:
9.3.5.1 Trials and Approvals:
9.3.5.2 Acquisition and Mergers:
9.3.6 SWOT Analysis
9.4 Koninklijke Philips N.V.
9.4.1 Company Overview
9.4.2 Financial Analysis
9.4.3 Segmental and Regional Analysis
9.4.4 Research & Development Expense
9.4.5 Recent strategies and developments:
9.4.5.1 Partnerships, Collaborations, and Agreements:
9.4.5.2 Product Launches and Product Expansions:
9.4.5.3 Acquisition and Mergers:
9.4.6 SWOT Analysis
9.5 B. Braun Melsungen AG
9.5.1 Company Overview
9.5.2 Financial Analysis
9.5.3 Segmental and Regional Analysis
9.5.4 Research & Development Expenses
9.5.5 Recent strategies and developments:
9.5.5.1 Partnerships, Collaborations, and Agreements:
9.5.6 SWOT Analysis
9.6 Medtronic PLC
9.6.1 Company overview
9.6.2 Financial Analysis
9.6.3 Segmental and Regional Analysis
9.6.4 Research & Development Expenses
9.6.5 Recent strategies and developments:
9.6.5.1 Partnerships, Collaborations, and Agreements:
9.6.6 SWOT Analysis
9.7 Boston Scientific Corporation
9.7.1 Company Overview
9.7.2 Financial Analysis
9.7.3 Segmental and Regional Analysis
9.7.4 Research & Development Expense
9.7.5 Recent strategies and developments:
9.7.5.1 Trials and Approvals:
9.7.5.2 Acquisition and Mergers:
9.7.6 SWOT Analysis
9.8 Terumo Corporation
9.8.1 Company Overview
9.8.2 Financial Analysis
9.8.3 Segmental and Regional Analysis
9.8.4 Research & Development Expenses
9.8.5 Recent strategies and developments:
9.8.5.1 Partnerships, Collaborations, and Agreements:
9.8.6 SWOT Analysis
9.9 GE HealthCare Technologies, Inc.
9.9.1 Company Overview
9.9.2 Financial Analysis
9.9.3 Segmental and Regional Analysis
9.9.4 Research & Development Expenses
9.9.5 Recent strategies and developments:
9.9.5.1 Partnerships, Collaborations, and Agreements:
9.9.6 SWOT Analysis
9.10. Stryker Corporation
9.10.1 Company Overview
9.10.2 Financial Analysis
9.10.3 Segmental and Regional Analysis
9.10.4 Research & Development Expense
9.10.5 Recent strategies and developments:
9.10.5.1 Partnerships, Collaborations, and Agreements:
9.10.5.2 Product Launches and Product Expansions:
9.10.5.3 Trials and Approvals:
9.10.6 SWOT Analysis
Unique Offerings 